Companies and Brands
Why Altria's New Partner Could Be a Game Changer
Published:
Last Updated:
Altria Group Inc. (NYSE: MO) is entering a new partnership with Lexaria Nicotine to fund the research and development of Lexaria’s patented DehydraTECH technology. The partnership will explore innovation in oral, reduced-risk nicotine consumer products and potentially commercialize DehydraTECH for oral nicotine delivery.
Lexaria’s DehydraTECH enhances the performance of beneficial compounds in ingestible products across four categories: taste and smell, speed of action, bio-absorption and bioavailability.
In exchange for a minority equity interest Altria Ventures, an indirect Altria Group subsidiary, will fund up to $12 million for Lexaria Nicotine to conduct milestone-based clinical investigations utilizing DehydraTECH.
Under the terms of the deal, Altria will pay Lexaria Nicotine a royalty on revenue generated from the sale of nicotine products containing DehydraTECH, and it holds the option to acquire 100% ownership in Lexaria Nicotine, at which time royalty payments would stop.
Additionally, Altria has the right to initially appoint one of the seven directors on Lexaria Nicotine’s board of directors and, through further phased investments, may have the right to appoint up to three of the seven directors.
Chris Bunka, CEO of Lexaria Bioscience, commented:
This is an incredible milestone for Lexaria Bioscience and our shareholders. We are proud that Altria has chosen to invest in our DehydraTECH technology and look forward to reaping the benefits of working with a world-class partner. Together we have the opportunity to change nicotine delivery and make a difference in the lives of millions of consumers.
Shares of Altria were last seen down almost 1% at $46.84, in a 52-week range of $46.49 to $71.86. The consensus analyst price target is $57.95.
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.